Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment

Zheng-Yu Liu1,2, Zi-Hui Yin3, Cheng-Yang Liang4

  • 1Department of Cardiology, Hunan Provincial People's Hospital, Changsha, Hunan, China.

Insights

Ultra-low contrast percutaneous coronary intervention (PCI) is safe for non-ST-elevated myocardial infarction (non-STEMI) patients with chronic kidney disease (CKD). This strategy preserves renal function and shows no major adverse events at 90 days.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • The safety and efficacy of percutaneous coronary intervention (PCI) using minimal contrast media in patients with non-ST-elevated myocardial infarction (non-STEMI) and chronic kidney disease (CKD) remain largely uncharacterized.
  • Assessing renal function preservation and short-term clinical outcomes is critical for this high-risk patient population undergoing revascularization.

Purpose of the Study:

  • To evaluate a strategy of ultra-low volume contrast PCI aimed at preserving renal function in non-STEMI patients with CKD.
  • To observe the 90-day clinical endpoint in this cohort.

Main Methods:

  • A prospective study included 29 non-STEMI patients with CKD (eGFR ≤60 mL/min/1.73 m²).
  • Ultra-low volume contrast PCI was performed using minimal contrast coronary angiography and zero-contrast optical coherence tomography (OCT) guidance.
  • Quantitative flow ratio (QFR) was used for pre-perfusion assessment and to verify procedural improvement.

Main Results:

  • The study included patients with a median creatinine of 2.1 mg/dL and mean eGFR of 48 mL/min/1.73 m².
  • Optical coherence tomography (OCT) identified abnormalities in 52% of cases post-dilation.
  • No significant changes in creatinine or eGFR were observed short- or long-term, and no major adverse events occurred.

Conclusions:

  • Ultra-low contrast PCI guided by QFR and zero-contrast OCT is a safe and feasible strategy for non-STEMI patients with high-risk CKD.
  • This approach can be performed without major adverse events, suggesting potential for renal function preservation in this vulnerable group.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
127
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
340
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
252
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
273
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
436
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
131